275 related articles for article (PubMed ID: 23301927)
1. Urinary nerve growth factor level in children with neurogenic bladder due to myelomeningocele.
Korzeniecka-Kozerska A; Porowski T; Michaluk-Skutnik J; Wasilewska A; Płoński G
Scand J Urol; 2013 Oct; 47(5):411-7. PubMed ID: 23301927
[TBL] [Abstract][Full Text] [Related]
2. Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder.
Yokoyama T; Kumon H; Nagai A
Neurourol Urodyn; 2008; 27(5):417-20. PubMed ID: 17924444
[TBL] [Abstract][Full Text] [Related]
3. Urinary NGF, TGF-β1, TIMP-2 and bladder wall thickness predict neurourological findings in children with myelodysplasia.
Şekerci ÇA; Işbilen B; Işman F; Akbal C; Şimşek F; Tarcan T
J Urol; 2014 Jan; 191(1):199-205. PubMed ID: 23973519
[TBL] [Abstract][Full Text] [Related]
4. [Sensitivity and specificity of urinary and serum neurotrophins in the diagnosis of neurogenic detrusor overactivity in multiple sclerosis].
Bazhenov IV; Filippova ES; Bazarnyi VV; Sazonov SV; Volkova LI; Zaitseva LN
Urologiia; 2018 Jul; (3):44-48. PubMed ID: 30035417
[TBL] [Abstract][Full Text] [Related]
5. Urinary nerve growth factor levels are elevated in patients with overactive bladder and do not significantly increase with bladder distention.
Liu HT; Kuo HC
Neurourol Urodyn; 2009; 28(1):78-81. PubMed ID: 19089891
[TBL] [Abstract][Full Text] [Related]
6. The role of urinary nerve growth factor for the diagnosis and assessment of the biofeedback success in children with dysfunctional voiding.
Ergin G; Kibar Y; Ebiloğlu T; Irkılata HC; Kopru B; Kaya E; Uyanık M; Tapan S; Dayanc MM
J Pediatr Urol; 2016 Apr; 12(2):118.e1-6. PubMed ID: 26701107
[TBL] [Abstract][Full Text] [Related]
7. The effect of intradetrusor botulinum neurotoxin type A on urinary NGF, TGF BETA-1, TIMP-2 levels in children with neurogenic detrusor overactivity due to myelodysplasia.
Top T; Sekerci CA; Isbilen-Basok B; Tanidir Y; Tinay I; Isman FK; Akbal C; Simsek F; Tarcan T
Neurourol Urodyn; 2017 Sep; 36(7):1896-1902. PubMed ID: 28090659
[TBL] [Abstract][Full Text] [Related]
8. Editorial comment. Effect of pelvic floor interferential electrostimulation on urodynamic parameters and incontinency of children with myelomeningocele and detrusor overactivity.
Bologna R
Urology; 2009 Aug; 74(2):329; author reply 329-30. PubMed ID: 19646616
[No Abstract] [Full Text] [Related]
9. Distribution of interstitial cells of Cajal in the neurogenic urinary bladder of children with myelomeningocele.
Piaseczna-Piotrowska A; Dzieniecka M; Samolewicz E; Leśniak D; Kulig A
Adv Med Sci; 2013; 58(2):388-93. PubMed ID: 24243750
[TBL] [Abstract][Full Text] [Related]
10. Effect of pelvic floor interferential electrostimulation on urodynamic parameters and incontinency of children with myelomeningocele and detrusor overactivity.
Kajbafzadeh AM; Sharifi-Rad L; Baradaran N; Nejat F
Urology; 2009 Aug; 74(2):324-9. PubMed ID: 19476983
[TBL] [Abstract][Full Text] [Related]
11. Postpubertal urodynamic and upper urinary tract changes in children with conservatively treated myelomeningocele.
Almodhen F; Capolicchio JP; Jednak R; El Sherbiny M
J Urol; 2007 Oct; 178(4 Pt 1):1479-82. PubMed ID: 17706702
[TBL] [Abstract][Full Text] [Related]
12. Increased nerve growth factor in neurogenic overactive bladder and interstitial cystitis patients.
Jacobs BL; Smaldone MC; Tyagi V; Philips BJ; Jackman SV; Leng WW; Tyagi P
Can J Urol; 2010 Feb; 17(1):4989-94. PubMed ID: 20156378
[TBL] [Abstract][Full Text] [Related]
13. Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment.
Liu HT; Kuo HC
Urology; 2008 Jul; 72(1):104-8; discussion 108. PubMed ID: 18400272
[TBL] [Abstract][Full Text] [Related]
14. Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection.
Liu HT; Chancellor MB; Kuo HC
Eur Urol; 2009 Oct; 56(4):700-6. PubMed ID: 18472208
[TBL] [Abstract][Full Text] [Related]
15. [NERVE GROWTH FACTOR IN THE URINE OF PATIENTS WITH IDIOPATHIC DETRUSOR OVERACTIVITY AND OVERACTIVE BLADDER WITHOUT DETRUSOR OVERACTIVITY].
Krivoborodov GG; Kolesanova EF; Tur EI; Efremov NS
Urologiia; 2015; (3):19-22. PubMed ID: 26390554
[TBL] [Abstract][Full Text] [Related]
16. Bladder compliance in meningomyelocele children.
Ghoniem GM; Bloom DA; McGuire EJ; Stewart KL
J Urol; 1989 Jun; 141(6):1404-6. PubMed ID: 2724439
[TBL] [Abstract][Full Text] [Related]
17. NGF and HB-EGF: potential biomarkers that reflect the effects of fesoterodine in patients with overactive bladder syndrome.
Kim SR; Moon YJ; Kim SK; Bai SW
Yonsei Med J; 2015 Jan; 56(1):204-11. PubMed ID: 25510766
[TBL] [Abstract][Full Text] [Related]
18. Repeated Botulinum-A toxin injection in the treatment of neuropathic bladder dysfunction and poor bladder compliance in children with myelomeningocele.
Horst M; Weber DM; Bodmer C; Gobet R
Neurourol Urodyn; 2011 Nov; 30(8):1546-9. PubMed ID: 21674597
[TBL] [Abstract][Full Text] [Related]
19. Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder.
Liu HT; Chancellor MB; Kuo HC
BJU Int; 2009 Jun; 103(12):1668-72. PubMed ID: 19220267
[TBL] [Abstract][Full Text] [Related]
20. Urinary nerve growth factor in children with overactive bladder: a promising, noninvasive and objective biomarker.
Oktar T; Kocak T; Oner-Iyidogan Y; Erdem S; Seyithanoglu M; Ziylan O; Kocak H
J Pediatr Urol; 2013 Oct; 9(5):617-21. PubMed ID: 22789557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
